Japan In Talks With Baxter, GSK For Emergency Flu Vaccines
This article was originally published in PharmAsia News
Executive Summary
Japan's Health Ministry is conducting separate talks with a pair of international drug makers to provide vaccines to prevent a pandemic of new virulent flu strains. Baxter International of the United States and GlaxoSmithKline of the United Kingdom have held talks with the ministry about getting marketing approval in Japan that would allow them to begin shipping supplies within three to six months after they apply. Both companies already have received orders for pre-pandemic flu vaccines from the U.S. and U.K. governments. (Click here for more - a subscription may be required